Working in Industry: Researchers Balance Work and Life

Indianapolis is the center for research and development for Eli Lilly and Co. Scientists at large pharmaceutical companies have access to colleagues in diverse areas. As a result, an individual may stumble across an opportunity that leads to a diversion from a logical career progression. Hedberg adds, "It is important to know that you have the responsibility for your own career management. If you are interested in pursuing these opportunities they are there for you to sample, but you have

Written byNadia Halim
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Though at one time researchers in academia may have looked down upon industry science, this is no longer true. Posada recalls, "When I went to graduate school there was the sentiment that people who couldn't make it in an academic setting would go into industry. That was very clear." However, in the last 10 years attitudes have changed. Advertisements for pharmaceutical companies are generating applications from talented people at top-level labs.

Posada still serves on a National Science Foundation study section panel reviewing grants twice a year. He adds, "If anything, I see academic scientists wishing they could tap into our resources. In fact, we work a lot with [researchers in academia] so we are actually seeing the line between public and private [sectors blurring]." Hedberg agrees, "Technologically and conceptually advanced science is pursued here, and it couldn't be any other way. We are driven by a competitive market, so ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies